Search and Filter
Results per Page:
New horizons in infectious disease treatment and prevention in immunocompromised patients
The 5th Symposium on Infectious Disease in the Immunocompromised Host emphasized new opportunities, next generation
American Society of Clinical Oncology honors Fred Hutch and UW hematology-oncology fellows
Five early-career researchers to each receive $50,000 toward innovative cancer research projects
Gene therapy delivery system successfully targets CD90+ hematopoietic stem cells in vivo
Fred Hutch laboratory research presented at the American Society of Gene and Cell Therapy’s annual meeting moves a promising approach one step closer to clinical trials
Drs. Keith Jerome and Jesse Bloom elected fellows of American Academy of Microbiology
Fred Hutch researchers’ study of viruses evolves from basic understanding to practical applications
With respiratory infections rampant, experts urge masking and vaccination
Limited disease data makes it hard to accurately assess flu trends
Starting the year smarter
How patients, providers, researchers and others stay informed amid a deluge of data and information
Laying the groundwork for a new cancer-preventive vaccine
Fred Hutch scientists garner large NCI award to uncover secrets of immune response to virus behind Kaposi sarcoma
Infectious disease experts propose trials network dedicated to immunocompromised patients
ImmunOptimize workshop convened stakeholders across disciplines to brainstorm infectious disease clinical trials network designed to serve people with weakened immune systems
Engineered HSV can trigger genetic chain reaction, rejigger HSV genes during co-infection
Proof-of-concept work raises hope that ‘gene drive’ could one day form basis of curative gene therapy for herpes
Zeroing in on vaginal microbes that most increase HIV risk
Signature combination of BV bacteria and immune proteins associated with highest risk could help guide prevention
$5.25M from the Kuni Foundation propels innovative adult oncology research
Grants will support research on tumor regression, immunotherapy access and better care for breast, liver and peritoneal malignancies
Fred Hutch and UW hematology-oncology fellows win ASCO Young Investigator Awards
Winners represent broad range of research
How to survive the holidays with cancer
Scientists, providers and patients offer tips on getting through the season after a diagnosis
Dr. Hans-Peter Kiem awarded amfAR grant for research on HIV gene therapy
Potential cure builds on unexpected findings about hematopoietic stem cells
Bridging the pain communication gap
Cancer patient and providers share experiences, tips on communicating pain to inform symptoms and treatments
Infectious disease scientists look beyond the pandemic
A symposium about protecting people with weakened immune systems from microbial threats
Going long: Viruses linger with lasting impact
Herpes, HIV, Epstein-Barr and other viruses hang around, causing potential long-term health woes. Should ‘long COVID’ surprise us?
How blood cancer research might help organ transplant patients
Fred Hutch study suggests certain immune cells are source of antibodies that attack donated organs
Eight Fred Hutch teams win Evergreen Fund awards
Research projects with commercial partnership potential receive grants of up to $200K
2022 Year in Review
A look at the most interesting and important stories of the past year